Cargando…
Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report
BACKGROUND: Although described by Hippocrates in 400 B.C., pemphigus disease still needs a safe therapeutical approach, given that the currently used therapies (i.e. corticosteroids and immunosuppressive drugs) often provoke collateral effects. Here we present preliminary data on the possible use of...
Autores principales: | Angelini, Giovanni, Bonamonte, Domenico, Lucchese, Alberta, Favia, Gianfranco, Serpico, Rosario, Mittelman, Abraham, Simone, Simone, Sinha, Animesh A, Kanduc, Darja |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630706/ https://www.ncbi.nlm.nih.gov/pubmed/17062151 http://dx.doi.org/10.1186/1479-5876-4-43 |
Ejemplares similares
-
Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous
por: Lucchese, Alberta, et al.
Publicado: (2006) -
Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10
por: Lucchese, Alberta, et al.
Publicado: (2004) -
Modeling the bound conformation of Pemphigus Vulgaris-associated peptides to MHC Class II DR and DQ Alleles
por: Tong, Joo Chuan, et al.
Publicado: (2006) -
Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model
por: Sajda, Thomas, et al.
Publicado: (2018) -
Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
por: Rosi-Schumacher, Mattie, et al.
Publicado: (2023)